The role of stress factors during aging of the immune system

Annals of the New York Academy of Sciences

Volumn 1153, Issue , 2009, Pages 139-152

  Bauer, Moisés E ^a   Jeckel, Cristina M Moriguchi ^a   Luz, Clarice ^b  

^a PONTIFICAL CATHOLIC UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b LabVitrus   (Brazil)

Author keywords

Aging; Glucocorticoids; Immunosenescence; Lymphocytes

Indexed keywords

GLUCOCORTICOID; GROWTH HORMONE; HYDROCORTISONE; PRASTERONE; PRASTERONE SULFATE;

ADAPTIVE IMMUNITY; AGING; ALLOSTASIS; CELL MIGRATION; CHRONIC STRESS; CONFERENCE PAPER; CYTOKINE PRODUCTION; DRUG EXPOSURE; EMOTIONAL STRESS; HORMONE RELEASE; HOSPITALIZATION COST; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; IMMUNE SYSTEM; INFLAMMATION; INNATE IMMUNITY; MORBIDITY; MORTALITY; NATURAL KILLER T CELL; NEUROENDOCRINE SYSTEM; NONHUMAN; OXIDATIVE STRESS; PSYCHOSOCIAL CARE; QUALITY OF LIFE; RISK ASSESSMENT; SENESCENCE; STRESS; TELOMERE;

EID: 60349095684     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2008.03966.x     Document Type: Conference Paper

References (125)

1. Franceschi, C. et al. 1996. Successful imunosenescence and the remodelling of immune responses with ageing. Nephrol. Dial. Transplant. 11 : 18 25.
2. Castle, S.C. 2000. Clinical relevance of age-related immune dysfunction. Clin. Infec. Dis. 31 : 578 585.
3. Bauer, M.E. 2005. Stress, glucocorticoids and ageing of the immune system. Stress 8 : 69 83.
4. McEwen, B. et al. 1997. The role of adrenocorticosteroids as modulators of immune function in health and disease: neural, endocrine and immune interactions. Brain Res. Rev. 23 : 79 133.
5. Fauci, A. 1975. Mechanisms of corticosteroid action on lymphocyte subpopulations. Immunology 28 : 669 679.
6. Aspinall, R. & D. Andrew. 2000. Thymic atrophy in the mouse is a soluble problem of the thymic environment. Vaccine 18 : 1629 1637.
7. Henson, S.M., J. Pido-Lopez & R. Aspinall. 2004. Reversal of thymic atrophy. Exp. Gerontol. 39 : 673 678.
8. Hannet, I. et al. 1992. Developmental and maturational changes in human blood lymphocyte subpopulations. Immunol. Today 13 : 215, 218.
9. Franceschi, C. et al. 1995. The immunology of exceptional individuals: the lesson of centenarians. Immunol. Today 16 : 12 16.
10. Fagnoni, F.F. et al. 1996. Expansion of cytotoxic CD8 +CD28- T cells in healthy ageing people, including centenarians. Immunology 88 : 501 507.
11. Franceschi, C., M. Bonafš & S. Valensini. 2000. Human immunosenescence: the prevailing of innate immunity, the failing of clonotypic immunity, and the filling of immunological space. Vaccine 18 : 1717 1720.
12. Effros, R. 1997. Loss of CD28 expression on T lymphocytes: a marker of replicative senescence. Dev. Comp. Immunol. 21 : 471 478.
13. Zhang, X. et al. 2002. Aging leads to disturbed homeostasis of memory phenotype CD8(+) cells. J. Exp. Med. 195 : 283 293.
14. Batliwalla, F. et al. 1996. Oligoclonality of CD8+ T cells in health and disease: aging, infection, or immune regulation? Hum. Immunol. 48 : 68 76.
15. Effros, R.B. et al. 2005. The role of CD8+ T-cell replicative senescence in human aging. Immunol. Rev. 205 : 147 157.
16. Brzezinska, A. et al. 2004. Proliferation and apoptosis of human CD8(+)CD28(+) and CD8(+)CD28(-) lymphocytes during aging. Exp. Gerontol. 39 : 539 544.
17. Liu, J. et al. 1997. The monitoring biomarker for immune function os lymphocytes in the elderly. Mech. Ageing Dev. 94 : 177 182.
18. Murasko, D., P. Weiner & D. Kaye. 1987. Decline in mitogen induced proliferation of lymphocytes with increasing age. Clin. Exp. Immunol. 70 : 440 448.
19. Ginaldi, L. et al. 2001. Immunosenescence and infectious diseases. Microbes Infection. 3 : 851 857.
20. Globerson, A. & R. Effros. 2000. Ageing of lymphocytes and lymphocytes in the aged. Immunol. Today 21 : 515 521.
21. Fontenot, J.D., M.A. Gavin & A.Y. Rudensky. 2003. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat. Immunol. 4 : 330 336.
22. Sakaguchi, S. 2000. Regulatory T cells: key controllers of immunologic self-tolerance. Cell 101 : 455 458.
23. Trzonkowski, P. et al. 2006. CD4+CD25+ T regulatory cells inhibit cytotoxic activity of CTL and NK cells in humans-impact of immunosenescence. Clin. Immunol. 119 : 307 316.
24. Wack, A. et al. 1998. Age-related modifications of the human alphabeta T cell repertoire due to different clonal expansions in the CD4+ and CD8+ subsets. Int. Immunol. 10 : 1281 1288.
25. Kohler, S. et al. 2005. Post-thymic in vivo proliferation of naive CD4+ T cells constrains the TCR repertoire in healthy human adults. Eur. J. Immunol. 35 : 1987 1994.
26. Plackett, T.P. et al. 2004. Aging and innate immune cells. J. Leukoc. Biol. 76 : 291 299.
27. Di Lorenzo, G. et al. 1999. Granulocyte and natural killer activity in the elderly. Mech. Ageing Dev. 108 : 25 38.
28. Agrawal, A. et al. 2007. Altered innate immune functioning of dendritic cells in elderly humans: a role of phosphoinositide 3-kinase-signaling pathway. J. Immunol. 178 : 6912 6922.
29. Della Bella, S. et al. (2007. Peripheral blood dendritic cells and monocytes are differently regulated in the elderly. Clin. Immunol. 122 : 220 228.
30. Grewe, M. 2001. Chronological ageing and photoageing of dendritic cells. Clin. Exp. Dermatol. 26 : 608 612.
31. Steger, M.M., C. Maczek & B. Grubeck-Loebenstein. 1997. Peripheral blood dendritic cells reinduce proliferation in in vitro aged T cell populations. Mech. Ageing Dev. 93 : 125 130.
32. van Duin, D. et al. 2007. Prevaccine determination of the expression of costimulatory B7 molecules in activated monocytes predicts influenza vaccine responses in young and older adults. J. Infect. Dis. 195 : 1590 1597.
33. Ginaldi, L. et al. 1999. Immunological changes in the elderly. Aging Clin. Exp. Res. 11 : 281 286.
34. Krishnaraj, R. 1997. Senescence and cytokines modulate the NK cell expression. Mech. Ageing Dev. 96 : 89 101.
35. Rukavina, D. et al. 1998. Age-related decline of perforin expression in human cytotoxic T lymphocytes and natural killer cells. Blood 92 : 2410 2420.
36. Mocchegiani, E. & M. Malavolta. 2004. NK and NKT cell functions in immunosenescence. Aging Cell. 3 : 177 184.
37. Pawelec, G. 1999. Immunosenescence: impact in the young as well as the old? Mech. Ageing Dev. 108 : 1 7.
38. Licastro, F. et al. 2005. Innate immunity and inflammation in ageing: a key for understanding age-related diseases. Immun. Ageing. 2 : 8.
39. Franceschi, C. et al. 2000. Inflamm-aging. An evolutionary perspective on immunosenescence. Ann. N. Y. Acad. Sci. 908 : 244 254.
40. Luz, C. et al. 2003. Impact of psychological and endocrine factors on cytokine production of healthy elderly people. Mech. Ageing Dev. 124 : 887 895.
41. Roshan, S., S. Nader & P. Orlander. 1999. Ageing and hormones. Eur. J. Clin. Invest. 29 : 210 213.
42. Canning, M.O. et al. 2000. Opposing effects of dehydroepiandrosterone and dexamethasone on the generation of monocyte-derived dendritic cells. Eur. J. Endocrinol. 143 : 687 695.
43. Migeon, C. et al. 1957. Dehydroepiandrosterone and androsterone levels in human plasma: effects of age, sex, day to day diurnal variations. J. Clin. Endocrinol. Metab. 17 : 1051.
44. Heuser, I. et al. 1998. Increased diurnal plasma concentrations of dehydroepiandrosterone in depressed patients. J. Clin. Endocrinol. Metab. 83 : 3130 3133.
45. Vedhara, K. et al. 1999. Chronic stress in elderly carers of dementia patients and antibody response to influenza vaccination. Lancet 353 : 627 631.
46. Kiecolt-Glaser, J.K. et al. 1996. Chronic stress alters the immune response to influenza virus vaccine in older adults. Proc. Natl. Acad. Sci. USA 93 : 3043 3047.
47. Sternberg, E. 2002. Neuroendocrine regulation of autoimmune/inflammatory disease. J. Endocrinol. 169 : 429 435.
48. Straub, R., J. Schölmerich & M. Cutolo. 2003. The multiple facets of premature aging in rheumatoid arthritis. Arthritis Rheumatism 48 : 2713 2721.
49. Straub, R. et al. 2000. Cytokines and hormones as possible links between endocrinosenescence and immunosenescence. J. Neuroimmunol. 109 : 10 15.
50. Besedovsky, H. et al. 1977. Hypothalamic changes during the immune response. Eur. J. Immunol. 7 : 323 325.
51. Mastorakos, G., G.P. Chrousos & J. Weber. 1993. Recombinant IL-6 activates the hypothalamic-pituitary-adrenal axis in humans. J. Clin. Endocrinol. Metab. 77 : 1690 1694.
52. Daynes, R. et al. 1993. Altered regulation of IL-6 production with normal aging - possible linkage to the age-associated decline in dehydroepiandrosterone and its sulfated derivative. J. Immunol. 150 : 5219 5230.
53. Straub, R.H. et al. 1998. Serum dehydroepiandrosterone (DHEA) and DHEA sulfate are negatively correlated with serum interleukin-6 (IL-6), and DHEA inhibits IL-6 secretion from mononuclear cells in man in vitro: possible link between endocrinosenescence and immunosenescence. J. Clin. Endocrinol. Metab. 83 : 2012 2017.
54. Vetta, F. et al. 2001. Tumor necrosis factor-alpha and mood disorders in the elderly. Arch. Gerontol. Geriat. Suppl. 7 : 442.
55. Gabriel, P., I. Cakman & L. Rink. 2002. Overproduction of monokines by leukocytes after stimulation with lipopolysaccharide in the elderly. Exp. Gerontol. 37 : 235 247.
56. Fagiolo, U. et al. 1993. Increased cytokine production in mononuclear cells of healthy elderly people. Eur. J. Immunol. 23 : 2375 2378.
57. Schiepers, O.J., M.C. Wichers & M. Maes. 2005. Cytokines and major depression. Prog. Neuropsychopharmacol. Biol. Psychiatry 29 : 201 217.
58. Trzonkowski, P. et al. 2004. Immune consequences of the spontaneous pro-inflammatory status in depressed elderly patients. Brain. Behav. Immun. 18 : 135 148.
59. Piani, A. et al. 2004. Sleep disturbances in elderly: a subjective evaluation over 65. Arch. Gerontol. Geriatr. Suppl. 325 331.
60. Howieson, D.B. et al. 2003. Natural history of cognitive decline in the old old. Neurology 60 : 1489 1494.
61. Reynolds, C.F. 3rd. et al. 1998. Effects of age at onset of first lifetime episode of recurrent major depression on treatment response and illness course in elderly patients. Am. J. Psychiatry 155 : 795 799.
62. Collaziol, D. et al. 2004. Psychoneuroendocrine correlates of lymphocyte subsets during healthy ageing. Mech. Ageing Dev. 125 : 219 227.
63. Nolen-Hoeksema, S. & C. Ahrens. 2002. Age differences and similarities in the correlates of depressive symptoms. Psychol. Aging 17 : 116 124.
64. Deuschle, M. et al. 1997. With aging in humans the activity of the hypothalamus-pituitary-adrenal system increases and its amplitude flattens. Life Sci. 61 : 2239 2246.
65. Ferrari, E. et al. 2000. Pineal and pituitary-adrenocortical function in physiological aging and in senile dementia. Exp. Gerontol. 35 : 1239 1250.
66. Van Cauter, E., R. Leproult & D.J. Kupfer. 1996. Effects of gender and age on the levels and circadian rhythmicity of plasma cortisol. J. Clin. Endocrinol. Metab. 81 : 2468 2473.
67. Maeda, K. et al. 1991. Elevated urinary free cortisol in patients with dementia. Neurobiol. Aging 12 : 161 163.
68. Gold, P., F. Goodwin & G. Chrousos. 1988. Clinical and biochemical manifestations of depression I. N. Engl. J. Med. 319 : 348 413.
69. Kirschbaum, C. et al. 1995. Persistent high cortisol responses to repeated psychological stress in a subpopulation of healthy men. Psychol. Med. 57 : 468 474.
70. Bauer, M.E. et al. 2000. Chronic stress in caregivers of dementia patients is associated with reduced lymphocyte sensitivity to glucocorticoids. J. Neuroimmunol. 103 : 84 92.
71. Luz, C. et al. 2006. Healthy aging is associated with unaltered production of immunoreactive growth hormone but impaired neuroimmunomodulation. Neuroimmunomodulation 13 : 90 99.
72. Ferrari, E. et al. 2001. Age-related changes of the hypothalamic- pituitary-adrenal axis: pathophysiological correlates. Eur. J. Endocrinol. 144 : 319 329.
73. Butcher, S.K. & J.M. Lord. 2004. Stress responses and innate immunity: aging as a contributory factor. Aging Cell. 3 : 151 160.
74. Selye, H. 1936. A syndrome produced by diverse nocuous agents. Nature 138 : 32.
75. Sapolsky, R.M., L.M. Romero & A.U. Munck. 2000. How do glucocorticoids influence stress responses? Integrating permissive, suppressive, stimulatory, and preparative actions. Endocr. Rev. 21 : 55 89.
76. Biondi, M. 2001. Effects of stress on immune functions: an overview. In Psychoneuroimmunonology, Vol. 2. R. Ader, D. Felten & N. Cohen, Eds 189 226. Academic Press. San Diego.
77. Bauer, M.E. et al. 2002. Dexamethasone-induced effects on lymphocyte distribution and expression of adhesion molecules in treatment resistant major depression. Psychiat. Res. 113 : 1 15.
78. Hoglund, C.O. et al. 2006. Changes in immune regulation in response to examination stress in atopic and healthy individuals. Clin. Exp. Allergy 36 : 982 992.
79. Navarro, J. et al. 2006. Circulating dendritic cells subsets and regulatory T-cells at multiple sclerosis relapse: differential short-term changes on corticosteroids therapy. J. Neuroimmunol. 176 : 153 161.
80. Glaser, R. et al. 2001. Evidence for a shift in the Th-1 to Th-2 cytokine response associated with chronic stress and aging. J. Gerontol. Med. Sci. 56A : M477 M482.
81. Galon, J. et al. 2002. Gene profiling reveals unknown enhancing and suppressive actions of glucocorticoids on immune cells. FASEB J. 16 : 61 71.
82. Ramirez, F. et al. 1996. Glucocorticoids promote a Th2 cytokine response by CD4+ T cells in vitro. J. Immunol. 156 : 2406 2412.
83. Daynes, R., D. Dudley & B. Araneo. 1990. Regulation of murine lymphokine production in vivo. II. Dehydroepiandrosterone is a natural enhancer of interleukin-2 synthesis by helper T cells. Eur. J. Immunol. 20 : 793 802.
84. Suzuki, T. et al. 1991. Dehydroepiandrosterone enhances IL2 production and cytotoxic effector function of human T cells. Clin. Immunol. Immunopathol. 61 : 202 211.
85. Padgett, D.A. & R. Loria. 1994. In vitro potentiation of lymphocyte activation by dehydroepiandrosterone, androstenediol, and androstenetriol. J. Immunol. 153 : 1544 1552.
86. McLachlan, J.A., C.D. Serkin & O. Bakouche. 1996. Dehydroepiandrosterone modulation of lipopolysaccharide-stimulated monocyte cytotoxicity. J. Immunol. 156 : 328 335.
87. Di Santo, E., M. Sironi & T. Mennini. 1996. A glucocorticoid receptor independent mechanism for neurosteroid inhibition of tumor necrosis factor production. Eur. J. Pharmacol. 299 : 179 186.
88. Solerte, S.B. et al. 1999. Dehydroepiandrosterone sulfate enhances natural killer cell cytotoxicity in humans via locally generated immunoreactive insulin- like growth factor I. J. Clin. Endocrinol. Metab. 84 : 3260 3267.
89. Buvat, J. 2003. Androgen therapy with dehydroepiandrosterone. World J. Urol. 21 : 346 355.
90. Casson, P.R. et al. 1993. Oral dehydroepiandrosterone in physiologic doses modulates immune function in postmenopausal women. Am. J. Obstet. Gynecol. 169 : 1536 1539.
91. Araneo, B., M. Woods & R. Daynes. 1993. Reversal of the immunosenescent phenotype by dehydroepiandrosterone: hormone treatment provides an adjuvant effect on the immunization of aged mice with recombinant hepatitis B surface antigen. J. Infect. Dis. 167 : 830 840.
92. Danenberg, H. et al. 1995. Dehydroepiandrosterone (DHEA) treatment reverses the impaired immune response of old mice to influenza vaccination and protects from influenza infection. Vaccine 13 : 1445 1448.
93. Ribeiro, F. et al. 2007. Dehydroepiandrosterone sulphate enhances IgG and interferon-gamma production during immunization to tuberculosis in young but not aged mice. Biogerontology 8 : 209 220.
94. Degelau, J., D. Guay & H. Hallgren. 1997. The effect of DHEAS on influenza vaccination in aging adults. J. Amer. Geriatr. Soc. 45 : 747 751.
95. Evans, T.G. et al. 1996. The use of oral dehydroepiandrosterone sulfate as an adjuvant in tetanus and influenza vaccination of the elderly. Vaccine 14 : 1531 1537.
96. Ben-Yehuda, A. et al. 1998. The influence of sequential annual vaccination and DHEA administration on the efficacy of the immune response to influenza vaccine in the elderly. Mech. Ageing Dev. 102 : 299 306.
97. Danenberg, H.D. et al. 1997. Dehydroepiandrosterone treatment is not beneficial to the immune response to influenza in elderly subjects. J. Clin. Endocrinol. Metab. 82 : 2911 2914.
98. Corpas, S., M. Harman & M.R. Blackmann. 1993. Human growth hormone and human aging. Endocr. Rev. 14 : 20 39.
99. Kelley, K.W. 1990. The role of growth hormone in modulation of the immune response. Ann. N. Y. Acad. Sci. 594 : 95 103.
100. LeRoith, D. et al. 1996. The effects of growth hormone and insulin-like growth factor I on the immune system of aged female monkeys. Endocrinology 137 : 1071 1079.
101. Welniak, L.A., R. Sun & W.J. Murphy. 2002. The role of growth hormone in T-cell development and reconstitution. J. Leukoc. Biol. 71 : 381 387.
102. Weigent, D.A. et al. 1988. Production of immunoreactive growth hormone by mononuclear leukocytes. Faseb J. 2 : 2812 2818.
103. Hattori, N. et al. 1994. Spontaneous growth hormone (GH) secretion by unstimulated human lymphocytes and the effects of GH-releasing hormone and somatostatin. J. Clin. Endocrinol. Metab. 79 : 1678 1680.
104. Malarkey, W.B. et al. 2002. Human lymphocyte growth hormone stimulates interferon gamma production and is inhibited by cortisol and norepinephrine. J. Neuroimmunol. 123 : 180 187.
105. Wu, H. et al. 1999. Chronic stress associated with spousal caregiving of patients with Alzheimer's dementia is associated with downregulation of B-lymphocyte GH mRNA. J. Gerontol. A Biol. Sci. Med. Sci. 54 : M212 215.
106. Dixit, V.D. et al. 2004. Ghrelin inhibits leptin- and activation-induced proinflammatory cytokine expression by human monocytes and T cells. J. Clin. Invest. 114 : 57 66.
107. Englander, E.W., G.A. Gomez & G.H. Greeley, Jr. 2004. Alterations in stomach ghrelin production and in ghrelin-induced growth hormone secretion in the aged rat. Mech. Ageing Dev. 125 : 871 875.
108. Kavelaars, A. et al. 1996. Ontogeny of the response of human peripheral blood T cells to glucocorticoids. Brain Behav. Immun. 10 : 288 297.
109. Sippell, W.G. et al. 1978. Longitudinal studies of plasma aldosterone, corticosterone, deoxycorticosterone, progesterone, 17-hydroxyprogesterone, cortisol, and cortisone determined simultaneously in mother and child at birth and during the early neonatal period. I. Spontaneous delivery. J. Clin. Endocrinol. Metab. 46 : 971 985.
110. Rohleder, N. et al. 2002. Age and sex steroid-related changes in glucocorticoid sensitivity of pro-inflammatory cytokine production after psychosocial stress. J. Neuroimmunol. 126 : 69 77.
111. Miller, G.E. et al. 2005. Clinical depression and regulation of the inflammatory response during acute stress. Psychosom. Med. 67 : 679 687.
112. Bauer, M.E. et al. 2003. Altered glucocorticoid immunoregulation in treatment resistant depression. Psychoneuroendocrinology 28 : 49 65.
113. Kirschbaum, C., K.M. Pirke & D.H. Hellhammer. 1993. The 'Trier Social Stress Test' - a tool for investigating psychobiological stress responses in a laboratory setting. Neuropsychobiology 28 : 76 81.
114. Kiecolt-Glaser, J. et al. 1991. Spousal caregivers of dementia victims: longitudinal changes in immunity and health. Psychosom. Med. 53 : 345 362.
115. Redinbaugh, E., R. McCallum & J. Kiecolt-Glaser. 1995. Recurrent syndromal depression in caregivers. Psychol. Aging 358 368.
116. Epel, E.S. et al. 2004. Accelerated telomere shortening in response to life stress. Proc. Natl. Acad. Sci. USA 101 : 17312 17315.
117. Glaser, R. et al. 2000. Chronic stress modulates the immune response to a pneumococcal pneumonia vaccine. Psychosom. Med. 62 : 804 807.
118. Kiecolt-Glaser, J. et al. 1995. Slowing of wound healing by psychological stress. Lancet 346 : 1194 1196.
119. Shaw, W.S. et al. 1999. Accelerated risk of hypertensive blood pressure recordings among Alzheimer caregivers. J. Psychosom. Res. 46 : 215 227.
120. Vitaliano, P.P. et al. 2002. A path model of chronic stress, the metabolic syndrome, and coronary heart disease. Psychosom. Med. 64 : 418 435.
121. Schulz, R. & S.R. Beach. 1999. Caregiving as a risk factor for mortality: the Caregiver Health Effects Study. Jama 282 : 2215 2219.
122. Kiecolt-Glaser, J.K. et al. 2003. Chronic stress and age-related increases in the proinflammatory cytokine IL-6. Proc. Natl. Acad. Sci. USA 100 : 9090 9095.
123. McEwen, B. 1998. Protective and damaging effects of stress mediators. N. Engl. J. Med. 338 : 171 179.
124. Lupien, S. et al. 1994. Basal cortisol levels and cognitive deficits in human aging. J. Neurosci. 14 : 2893 2903.
125. Starkman, M., D. Schteingart & M. Schork. 1981. Depressed mood and other psychiatric manifestations of Cushing's syndrome: relationship to hormone levels. Psychosom. Med. 43 : 3 18.